The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat ...

The agency expects to issue a decision by Aug. 31, and it is slated to decide on maintenance dosing for an intravenous form of the drug later this month.

The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...

Eisai and Biogen are one step away from deploying a more convenient version of their jointly developed Alzheimer’s treatment ...

The injection process is expected to take, on average, 15 seconds. As part of the SC-AI 360 mg weekly maintenance regimen, ...

Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) (OTCPK:ESAIY) announced that the U.S. Food and Drug Administration (FDA) ...

Merck (MRK) stock in focus as the company eyes 2025 launch of subcutaneous Keytruda amid a looming patent cliff for its ...

Supplements and injections are effective ways to treat vitamin B12 deficiencies. These are the benefits and potential risks ...

This leaflet answers some common questions about Gentamicin Injection. It does not contain all the available information. It does not take the place of talking to your healthcare professional.

B12 supplements come in various forms, including pills, sprays, and injections ... of B12 used in supplements are cyanocobalamin and methylcobalamin. Cyanocobalamin is the synthetic form of ...

IIT Bombay has developed needle-free shock syringes for painless, safe drug delivery, offering hope for a future without injection-related trauma. Tested on rats, it outperformed traditional needles ...

By applying the principles of shock-wave dynamics, we can design needle-free drug delivery systems that not only overcome the trauma associated with traditional injections but also pave the way ...